The agreement outlines a comprehensive plan to save lives, build a more resilient health system, and enhance both nations’ capacity to address emerging global health challenges.
The organization plans to construct the country’s first dedicated facility for treating Sickle Cell Disease and blood cancers, which will offer life-saving bone-marrow transplants that are currently unavailable within Uganda’s borders.
Results showed that the injectable regimen performed just as well as the daily oral dolutegravir-based therapy (TLD) but helped reduce the burden of daily medication.